usfda
Latest from usfda
US drug body approves 1st over-the-counter opioid overdose reversal drug Narcan
Naloxone rapidly reverses or blocks the effects of opioids, restoring normal respiration, especially when given within minutes of the first signs of an overdose.

Tamil Nadu firm told to suspend eye drops’ manufacturing
The manufacturers were directed to “stop the manufacturing activities of all the products under the category of ophthalmic preparations till the completion of investigation”, the report added.

Updated on Feb 05, 2023 09:28 AM IST
BySoumya Pillai and Divya Chandrababu, New Delhi/chennai
US approves new antibody treatment -- for arthritic cats
These lab-grown proteins have grabbed headlines during the pandemic for preventing high-risk people with Covid from getting severely ill.

J&J vaccine gets additional warning on bleeding aide effect
J&J vaccines has been accused of causing serious blood clots and compelling a rare bleeding disorder.

ChemoCentryx's avacopan, used to treat rare autoimmune disease, gets approval
The disease affects about 40,000 people in the United States, with about 4,000 new cases each year, according to the company.
